A Multicenter, Phase 2 Study of Tesetaxel plus Three Different PD-(L)1 Inhibitors in Patients with Triple-Negative, Locally Advanced or Metastatic Breast Cancer and Tesetaxel Monotherapy in Elderly Patients with HER2 Negative, Locally Advanced or Metastatic Breast Cancer
- Sabanathan, Dhanusha, (Primary Chief Investigator)
- Park, John (Associate Investigator)
- Gilchrist, Jenny, (Associate Investigator)
- Rai, Meenal, (Clinical Trial Unit Staff)
- Chapman, Nicola, (Clinical Trial Unit Staff)
Project: Research